Absci Corp

US · ABSI #2817 by market cap Listed 2021

9.22 -1.05 -10.22%

Live - 5344 symbols - heartbeat 433s ago · 2026-10-08 06:35

Pre-market 9.14 -0.87%

After-hours 9.25 +0.33%

Overnight 9.23 +0.11%

Market cap: 1.58B
P/E (TTM): -11.67
P/B: 6.43
EPS: -0.84
Div yield: 0.00%
52W pos: 71%

Reader sentiment Are you bullish or bearish on ABSI?

Anonymous reader poll. Unscientific, not investment advice.

About Absci Corp

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Founded: 2011
CEO: Mr. Sean McClain
Employees: 140
Headquarters: Vancouver, Washington, United States of America
Fiscal year end: 12-31
Website: absci.com

Company profile

Exchange: US
Symbol: ABSI
Market-cap rank: #2817
Listing date: 2021-07-22
Market cap: 1.58B
Float cap: 1.51B
Shares out: 171.61M
Float shares: 163.79M

Sectors & themes

Biotechnology ARK Portfolio AI medical concept stocks

Browse all sectors & themes

Quote time 2026-10-08 06:35:35 · For reference only, not investment advice and not tailored to your situation.